Unconfigured Ad
Collapse
New here? Stop in and introduce yourself. Where you are, what you work on, etc.
| Forums | Topics | Posts | Last Post |
|---|
No forums found.
There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by ECO, 11-21-2011, 08:25 PM
|
16 responses
55,213 views
0 reactions
|
Last Post
by plant_hunt
11-06-2019, 05:43 AM
|
||
|
Started by Fonz, 09-23-2008, 08:03 AM
|
0 responses
1,740 views
0 reactions
|
Last Post
by Fonz
09-23-2008, 08:03 AM
|
||
|
Started by Blaize, 09-15-2008, 11:26 PM
|
0 responses
2,955 views
0 reactions
|
Last Post
by Blaize
09-15-2008, 11:26 PM
|
||
|
Started by dan, 09-15-2008, 06:12 AM
|
1 response
3,153 views
0 reactions
|
Last Post
by apfejes
09-15-2008, 09:05 AM
|
||
|
Started by swaroom, 08-20-2008, 06:33 AM
|
3 responses
5,741 views
0 reactions
|
Last Post
by dan
09-15-2008, 02:31 AM
|
||
|
Started by Sismeiro, 09-10-2008, 05:31 AM
|
0 responses
3,076 views
0 reactions
|
Last Post
by Sismeiro
09-10-2008, 05:31 AM
|
||
|
Started by Melissa, 08-04-2008, 01:13 AM
|
11 responses
4,360 views
0 reactions
|
Last Post
by apfejes
09-05-2008, 09:06 AM
|
||
|
Started by SSS, 09-05-2008, 04:56 AM
|
0 responses
1,956 views
0 reactions
|
Last Post
by SSS
09-05-2008, 04:56 AM
|
||
|
Started by Roald, 08-11-2008, 04:01 AM
|
4 responses
3,714 views
0 reactions
|
Last Post
by Roald
08-28-2008, 04:16 AM
|
||
|
Started by costas, 08-28-2008, 01:29 AM
|
0 responses
2,268 views
0 reactions
|
Last Post
by costas
08-28-2008, 01:29 AM
|
||
|
Started by fizquierdo, 08-24-2008, 12:49 PM
|
0 responses
2,428 views
0 reactions
|
Last Post
by fizquierdo
08-24-2008, 12:49 PM
|
No topics found.
-
Page of 0
No photos found.
-
Page of 0
Webinars
Collapse
-
by SEQadmin2
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...-
Channel: Webinar Series
07-31-2026, 07:00 AM -
Recent Articles
Collapse
-
by SEQadmin2
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...-
Channel: Articles
07-31-2026, 11:01 AM -
-
by SEQadmin2
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...-
Channel: Articles
07-20-2026, 11:48 AM -
-
by SEQadmin2
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...-
Channel: Articles
07-09-2026, 11:10 AM -
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 08-20-2026, 11:17 AM
|
0 responses
11 views
0 reactions
|
Last Post
by SEQadmin2
08-20-2026, 11:17 AM
|
||
|
Started by SEQadmin2, 08-18-2026, 10:05 AM
|
0 responses
20 views
0 reactions
|
Last Post
by SEQadmin2
08-18-2026, 10:05 AM
|
||
|
Started by SEQadmin2, 08-13-2026, 12:22 PM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
08-13-2026, 12:22 PM
|